New Water-Soluble Boswellia Extract Broadens Joint-Health Applications
The new AquaLox ingredient from PLT Health Solutions is a water-soluble version of the company’s 5-Loxin joint-health ingredient.
Photo © iStockphoto.com/HansJoachim
Despite the popularity of Boswellia serrata extract in joint-health products, its lack of water-solubility and unpleasant taste has made it a challenging ingredient to work with in certain applications. But AquaLox, a new water-soluble Boswellia extract from PLT Health Solutions (Morristown, NJ), may allow for a much broader range of applications for the popular ayurvedic spice.
AquaLox is a water-soluble version of PLT’s established 5-Loxin ingredient, which has been studied for its beneficial effects on joint comfort and protection against cartilage degradation. PLT Health Solutions says the new ingredient has “a similar pharmacokinetic profile to 5-Loxin.”
In addition to its water-solubility, AquaLOX also marks a “major breakthrough” because of its pleasant taste profile, which PLT Solutions says now allows for the Boswellia serrata extract to be used in taste-sensitive delivery systems like gummies, chews, stick-packs, and shots for the first time.
“5-Loxin is a market-leading joint-health ingredient, available in well over a hundred consumer products on the market today,” says Seth Flowerman, executive vice president, PLT Health Solutions. “In a market that demands convenience and novel delivery systems, all Boswellia extracts were limited because of the challenging taste profile and lack of solubility-and the technology needed to achieve this was tricky. With AquaLOX, we are finally able to deliver on our customers’ wish list and extend the 5-Loxin franchise to a whole new range of products.”
Read more:
PLT Health Solutions Launches Trust-Building Initiative
More Evidence that Lecithin Delivery System Boosts Boswellia Bioavailability
MSM and Boswellic Acids Comparable to Glucosamine for Osteoarthritis Relief, Study Says
Michael Crane
Associate Editor
Nutritional Outlook Magazine
michael.crane@ubm.com
Judge denies CRN’s motion for preliminary injunction but its lawsuit against NY state will proceed
April 23rd 2024The judge in CRN's lawsuit against NY state's law banning the sale of weight management and muscle building supplements to minors has denied its motion for a preliminary injunction, but determined that CRN has standing to sue on behalf of its members.
Arla Foods to acquired whey nutrition business from Volac International
April 22nd 2024Arla Foods Ingredients has reached an agreement to acquire Volac’s Whey Nutrition business through a purchase of shares in Volac Whey Nutrition Holdings Limited and its subsidiary, Volac Whey Nutrition Limited and Volac Renewable Energy Limited.
